Description

Remaxol (succinic acid, meglumine) solution for infusions 400 ml. vial

Ingredients

Active ingredients: Succinic acid, meglumine.

Dosage

Dosage: The recommended dosage of Remaxol solution for infusions is determined by a healthcare provider based on the patient’s condition and needs.

Indications

Indications: Remaxol solution is indicated for use in patients requiring intravenous infusion therapy to support metabolic processes.

Contraindications

Contraindications: Do not use Remaxol solution if you are allergic to any of the ingredients. Consult with a healthcare provider for further guidance.

Directions

Directions: Remaxol solution is administered intravenously by a healthcare professional. Do not self-administer without proper medical supervision.

Scientific Evidence

Scientific evidence: Studies have shown that succinic acid and meglumine, the active ingredients in Remaxol solution, play a role in cellular metabolism and antioxidant defense mechanisms. These components have been researched for their potential therapeutic benefits in various conditions.

Additional Information

Pharmacological effects: Succinic acid is involved in the citric acid cycle and has been studied for its potential to enhance energy production in cells. Meglumine acts as a stabilizer and has properties that may support the body’s antioxidant systems.

Clinical trials: Clinical trials evaluating the efficacy of Remaxol solution in different patient populations are ongoing. Preliminary results suggest potential benefits in improving cellular function and metabolic processes.